Join to View Full Profile
15 Parkman StWac 835 Neurology AssociatesBoston, MA 02114
Phone+1 617-724-3914
Fax+1 617-726-6991
Are you Dr. Sandrock?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alfred Sandrock Jr., MD is a board certified neurologist in Boston, Massachusetts.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1989 - 1992
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1988 - 1989
Harvard Medical SchoolClass of 1988
Certifications & Licensure
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 3 citationsResults from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab.Tianle Chen, John O'Gorman, Carmen Castrillo-Viguera, Rajasimhan Rajagovindan, Gioacchino G Curiale
Alzheimer's & Dementia. 2024-05-01 - 7 citationsOverall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis.Ih Chang, Ludwig Kappos, Gavin Giovannoni, Peter A Calabresi, Alfred Sandrock
Multiple Sclerosis. 2022-12-01 - 19 citationsAlzheimer disease neuropathology in a patient previously treated with aducanumab.Edward D Plowey, Thierry Bussiere, Raj Rajagovindan, Jennifer Sebalusky, Stefan Hamann
Acta Neuropathologica. 2022-07-01
Press Mentions
Could Alzheimer’s Disease Be Eradicated? Here’s What We Know — and What We Don’tMay 5th, 2023- The FDA’s Accelerated Approval Process: When Drugs Are Cleared for Sale Based on Limited EvidenceOctober 18th, 2021
- Biogen in a Bind: The High-Stakes Fight over Alzheimer’s and What Makes a Drug WorthwhileJuly 25th, 2021
- Join now to see all
